Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low INR to Minimize bleeding with mechanical valves (LIMIT) vanguard phase
2019-004975-37Phase 3Active
- Sponsor
- Hamilton Health Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of warfarin, phenprocoumon and acenocoumarol in mechanical heart valve and cardiac morbidity, sponsored by Hamilton Health Sciences. Primary endpoint: Primary feasibility endpoint. Started Jun 2021; status: active.
02
Drugs
warfarinphenprocoumonacenocoumarol
03
Conditions
mechanical heart valvecardiac morbidity
Beyond the preview
Go deeper on 2019-004975-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004975-37.